TARO
Taro Pharmaceutical Industries Ltd.
NYSE
People also watch:SCRILCIIPXLTEVAUTHR
137.20-1.03 (-0.75%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close138.23
Open138.49
Bid137.48 x 400
Ask137.62 x 100
52wk Range122.99 - 157.99
Day's Range137.05 - 139.33
Volume160,716
Avg Vol (3m)295,014
As of 1:25 PM EDT. NYSE Real Time Price. Market open.
  • Capital Cubeyesterday

    Taro Pharmaceutical Industries Ltd. :TARO-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016

    Click here to see latest analysisTaro Pharmaceutical Industries Ltd. reports financial results for the year ended March 31, 2016.We analyze the earnings along side the following peers of Taro Pharmaceutical Industries Ltd. – Johnson & Johnson and Novartis AG Sponsored ADR (JNJ-US and NVS-US) that have also reported for this period.HighlightsGross margins widened from 78.40% […] (Read more...) The post Taro Pharmaceutical Industries Ltd. :TARO-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016 appeared first on CapitalCube.

  • Taro Pharmaceutical Industries Ltd. – Value Analysis (NYSE:TARO) : July 20, 2016
    Capital Cube7 days ago

    Taro Pharmaceutical Industries Ltd. – Value Analysis (NYSE:TARO) : July 20, 2016

    Click here to see latest analysisCapitalcube gives Taro Pharmaceutical Industries Ltd. a score of 88.Our analysis is based on comparing Taro Pharmaceutical Industries Ltd. with the following peers – Mylan N.V., Pfizer Inc., Merck & Co., Inc., Valeant Pharmaceuticals International, Inc., Johnson & Johnson, Teva Pharmaceutical Industries Limited Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, Teligent, […] (Read more...) The post Taro Pharmaceutical Industries Ltd. – Value Analysis (NYSE:TARO) : July 20, 2016 appeared first on CapitalCube.